Page last updated: 2024-12-07

1-ethyl-3-(3-dimethylaminoethyl)carbodiimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Ethyl-3-(3-dimethylaminoethyl)carbodiimide (EDC) is a widely used coupling reagent in organic synthesis, particularly for the formation of amide bonds. EDC is a water-soluble carbodiimide that reacts with carboxylic acids to form an activated intermediate, which can then react with amines to form amides. EDC is often used in peptide synthesis, where it is used to couple amino acids together to form peptides. EDC is also used in the synthesis of other compounds, such as esters, lactones, and lactams. EDC is a versatile reagent that can be used in a variety of applications, and it is a valuable tool for synthetic chemists. EDC is studied due to its wide applicability in various fields, including drug development, materials science, and biotechnology. The compound is also important in studying the formation and reactions of amides, which are essential building blocks in many natural and synthetic compounds. The study of EDC helps in understanding the mechanism of amide bond formation and in developing new and more efficient methods for synthesizing amides.'

1-ethyl-3-(3-dimethylaminoethyl)carbodiimide: carboxyl modifying agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122346
SCHEMBL ID342301
MeSH IDM0200255

Synonyms (9)

Synonym
carbodiimide wscd
1-ethyl-3-(3-dimethylaminoethyl)carbodiimide
1,2-ethanediamine, n'-(ethylcarbonimidoyl)-n,n-dimethyl-
n'-(ethylcarbonimidoyl)-n,n-dimethyl-1,2-ethanediamine
141650-20-6
SCHEMBL342301
IHQAJFDAWJOQSX-UHFFFAOYSA-N
n-ethyl-n'-(dimethylaminoethyl)carbodiimide
DTXSID20161783
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.54)18.7374
1990's24 (36.92)18.2507
2000's29 (44.62)29.6817
2010's9 (13.85)24.3611
2020's2 (3.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.03 (24.57)
Research Supply Index4.23 (2.92)
Research Growth Index6.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other68 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]